Executive readout · one minute
Call research workspace
Read the call alongside every captured source. slides, 8-K earnings release, 10-Q stay in one workspace.
IMVT
$33.78
+0.00%
IMVT
· Immunovant, Inc.
$33.78
+0.00 (+0.00%)
At close · Oct 1
Return incl. dividend (before tax)
Market Cap
$6.88B
Shares
206.55M
Volume · Sep 30
1.43M
Avg daily vol (3M)
1.22M
All earnings calls
Earnings call · FY2027 Q1
Immunovant, Inc. (IMVT) Q1 2027 Earnings Call
Research coverage
3 live sources
Open each available source without leaving this research workspace.
Diluted EPS
-$0.75
Net income
-$153.22M
Research materials
Open the source you need; every reader stays inside this workspace.
Company presentation
Slides
69 pages · use arrow keys or swipe to navigate
SEC filing · Item 2.02
8-K earnings release
Filed Aug 6, 2026 · complete as-filed document
SEC periodic report
10-Q report
Filed Aug 6, 2026 · complete as-filed document